STOCK TITAN
  1. Home
  2. Sec-filings
  3. tlph
  4. [EFFECT] TALPHERA, INC. SEC Filing

[EFFECT] TALPHERA, INC. SEC Filing

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
EFFECT
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date: April 1, 2026 4:00 P.M.
Form: S-3
CIK: 0001427925
Company Name: TALPHERA, INC.
File Number: 333-294580

Source: View Original Filing on SEC EDGAR

Talphera Inc

NASDAQ:TLPH

View TLPH Stock Overview →

TLPH Rankings

#5781 Ranked by Market Cap
N/A Ranked by Dividends

TLPH Latest News

Mar 25, 2026
Talphera Announces Two Abstracts Accepted for Presentation at AKI & CRRT 2026
Mar 23, 2026
Talphera Announces Fourth Quarter and Full Year 2025 Financial Results and Provides Corporate Update
Mar 18, 2026
Talphera to Host Virtual Investor & Analyst Event to Discuss Niyad® for Use in Continuous Renal Replacement Therapy (CRRT), on March 23, 2026
Mar 2, 2026
Talphera Announces 50% Enrollment Milestone in Ongoing NEPHRO-CRRT Registrational Trial
Nov 12, 2025
Talphera Announces Third Quarter 2025 Financial Results and Provides Corporate Update

TLPH Latest SEC Filings

Apr 1, 2026
[424B7] TALPHERA, INC. Prospectus Filed Pursuant to Rule 424(b)(7)
Mar 25, 2026
[Form 4] TALPHERA, INC. Insider Trading Activity
Mar 24, 2026
[S-3] TALPHERA, INC. Shelf Registration Statement
Mar 23, 2026
[10-K] TALPHERA, INC. Files Annual Report
Mar 23, 2026
[8-K] TALPHERA, INC. Reports Material Event

TLPH Stock Data

38.92M
33.91M
Drug Manufacturers - Specialty & Generic
Pharmaceutical Preparations
Link
United States
SAN MATEO